Morag Macdonald, Joint Head of the International Intellectual Property Group, is regularly named as a leader in the IP litigation field. She joined the Intellectual Property Group of Bird & Bird in 1985 having originally trained as a barrister and became a partner of the firm in 1989. Her original degree, from Cambridge University, was in Mathematics, Physics and Law. Her particular interests are all forms of IP disputes and strategic advice, especially in regards to international cross border IP strategy advice.
Reported UK IP trials in which she has been involved include Mentor -v- Hollister, Research Corporation’s SPC, Reckitt & Coleman -v- Richardson Vicks, Cartonneries de Thulin -v- White Knight, Stolt Comex Seaway ats Coflexip, Freelift -v- Stannah, Synthon -v- SKB, Associated Newspapers -v- Express Newspapers, Sir Robert McAlpine –v- Alfred McAlpine, McAllergan -v- Merz Pharma, Proctor & Gamble -v- Reckitt Benckiser, Baxter Healthcare -v- Abbott Laboratories, European Central Bank -v- DSS and Edwards Lifesciences -v- Corevalve.
In recent years she has been particularly involved in the coordination and running of various pan-European patent actions involving several jurisdictions in Europe not always including the United Kingdom. For example the patent litigation between Baxter -v- Pharmacia & Upjohn/Genetics Institute (in the Netherlands, Sweden, Germany and before the ICC), between NovoNordisk -v- DSM (in the UK, Belgium, the Netherlands and Germany), between GlaxoWellcome ats Hoffman la Roche (in Belgium and Germany) and between JCB -v- Manitou (in the UK and France), for Allergan (in the UK, the Netherlands and Sweden), Halliburton -v- Smith (in the UK and Italy) and Edwards Lifesciences -v- Cook Biotech (in the UK and German).
As well as IP litigation she has recently been the lead advocate in major cross border biotech arbitration, provided freedom to operate advice in the field of carbon capture and advised a financial services company on its patent strategy in over 40 jurisdictions.